State childhood hepatitis B vaccination information
Hepatitis B is a vaccine-preventable disease. The vaccine is safe and so effective at preventing hepatitis B infection and resulting chronic complications such as liver cancer, that the World Health Organization has declared it the world’s first “anti-cancer vaccine.” Timely vaccination, especially administration of the birth dose of the hepatitis B vaccine, is an essential component of the elimination of hepatitis B transmission in the United States.
In this section, you can compare the progress of vaccination coverage rates across the nation. For each of the 50 states and the District of Columbia, you will find data on birth dose vaccination coverage for infants and vaccination series completion for children age 19-35 months. State screening requirements and contacts for local Perinatal Hepatitis B Prevention Program coordinators are also listed.
The data was compiled by the Asian Liver Center from the National Immunization Survey, 1995-2009 (http://www.cdc.gov/vaccines/stats-surv/nis/default.htm#nis). The National Immunization Survey is a survey of immunization coverage among children, age 19 to 35 months, in the United States. As a result, this data may differ from any birth-cohort data collected by counties and states.